News

Pfizer has lagged behind the broader market over the past year, but analysts maintain a cautiously optimistic outlook on the ...
Merck is a strong and profitable pick meeting Benjamin Graham's criteria. Read more on why investors need to stay aware of ...
Jim Cramer threw a curveball on Pfizer’s stock during a recent caller interaction, suggesting a wait-and-see approach ...
Zacks Investment Research on MSN11h
Merck (MRK) Tops Q2 Earnings Estimates
Merck (MRK) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $2.28 per share a year ago. These figures are ...
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Virtus Dividend, Interest & Premium Strategy Fund offers a 9.52% yield and outperforms major indices, making it attractive ...
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the Stocks With Huge Catalysts on the Horizon. On May 13, Advanced Micro ...
Pinnacle Associates Ltd. increased its Danaher holdings by 5.3%, now owning shares worth $5.42 million. Institutional ...